Thi Hong Van NGUYEN

Dr. Thi Hong Van NGUYEN

Aix-Marseille University, Marseille, Provence-Alpes-Côte d’Azur, France
orcid
Specialist Researcher

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Acta Crystallographica Section D Structural Biology
Verified
Journal Article
Closed access
PDF file
Thi Hong Van NGUYENThi Hong Van NGUYEN
Thi Hong Van NGUYEN
JLJulie Lichière
Julie Lichière
BCBruno Canard
Bruno Canard
NPNicolas Papageorgiou
Nicolas Papageorgiou
SASarah Attoumani
Sarah Attoumani
BCBruno Coutard
Bruno Coutard

17 July 2020 in Viruses
Verified
Journal Article
Open access
PDF file
NPNicolas Papageorgiou
Nicolas Papageorgiou
MSMaria Spiliopoulou
Maria Spiliopoulou
Thi Hong Van NGUYENThi Hong Van NGUYEN
Thi Hong Van NGUYEN
AVAfroditi Vaitsopoulou
Afroditi Vaitsopoulou
ELElsie Yekwa Laban
Elsie Yekwa Laban
FFFrançois Ferron
François Ferron
Arenaviridae is a family of viruses harbouring important emerging pathogens belonging to the Bunyavirales order. Like in other segmented negative strand RNA viruses, the nucleoprotein (NP) is a major actor of the viral life cycle being both (i) the necessary co-factor of the polymerase present in the L protein, and (ii) the last line of defence of the viral genome (vRNA) by physically hiding its presence in the cytoplasm. The NP is also one of the major players interfering with the immune system. Several structural studies of NP have shown that it features two domains: a globular RNA binding domain (NP-core) in its N-terminal and an exonuclease domain (ExoN) in its C-terminal. Further studies have observed that significant conformational changes are necessary for RNA encapsidation. In this review we revisited the most recent structural and functional data available on Arenaviridae NP, compared to other Bunyavirales nucleoproteins and explored the structural and functional implications. We review the variety of structural motif extensions involved in NP–NP binding mode. We also evaluate the major functional implications of NP interactome and the role of ExoN, thus making the NP a target of choice for future vaccine and antiviral therapy.

23 April 2004 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
UAUwe Albrecht
Uwe Albrecht
Thi Hong Van NGUYENThi Hong Van NGUYEN
Thi Hong Van NGUYEN
PLPeter Langer
Peter Langer

25 February 2021 in FEBS Open Bio
Verified
Journal Article
Open access
NPNicolas Papageorgiou
Nicolas Papageorgiou
AVAfroditi Vaitsopoulou
Afroditi Vaitsopoulou
ADAWA DIOP
AWA DIOP
Thi Hong Van NGUYENThi Hong Van NGUYEN
Thi Hong Van NGUYEN
BCBruno Canard
Bruno Canard
FFFrançois Ferron
François Ferron
Arenaviruses are enveloped viruses containing a segmented, negative, and ambisense single-stranded RNA genome wrapped with a nucleoprotein (NP). The NP is the most abundant viral protein in infected cells and plays a critical role in both replication/transcription and virion assembly. The NP associates with RNA to form a ribonucleoprotein (RNP) complex, and this implies self-assembly while the exact structure of this polymer is not yet known. Here, we report a measurement of the full-length Mopeia virus NP by negative stain transmission electron microscopy. We observed RNP complex particles with diameter 15 +/- 1 nm as well as symmetric circular heptamers of the same diameter, consistent with previous observations.

11 August 2024 in JACS Au
Verified
Journal Article
Open access
Kazuma MurakamiKazuma Murakami
Kazuma Murakami
Thi Hong Van NGUYENThi Hong Van NGUYEN
Thi Hong Van NGUYEN
CNChioko Nagao
Chioko Nagao
KMKenji Mizuguchi
Kenji Mizuguchi
Gal BitanGal Bitan
Gal Bitan
Inhibition of amyloidogenic-protein oligomeriza- tion and aggregation is a promising therapy-development strategy for proteinopathies, such as Alzheimer’s and Parkinson’s diseases, in which proteins self-associate into a variety of abnormal, toxic assemblies. Despite discovery of numerous compounds modulating the self-assembly process in vitro, few have reached advanced clinical trials, and none have translated into effective therapy to date. A potential reason is a lack of clear mechanistic under- standing of the interaction between the inhibitors/modulators and the target metastable protein assemblies. A unique class of compounds targets specifically Lys residues, which have been shown to be important mediators of many amyloidogenic-protein aberrant self-assembly processes due to their participation in both electrostatic and hydrophobic interactions. Although seemingly paradoxical, as these compounds do not target a specific protein, compounds targeting Lys show a remarkable ability to selectively disrupt the interactions mediating abnormal protein self-assembly. Such compounds include covalent and noncovalent Lys-binding small molecules, as well as agents controlling Lys-post-translational modification (PTM). Recent advances in this area show that the application of Lys-targeting inhibitors in antiamyloid drug discovery campaigns and Lys-reactive rational-design approaches have led to intriguing results in multiple systems, including animal models of various proteinopathies. As this strategy is applicable and promising for targeting most of the proteins involved in proteinopathies, including amyloid β -protein, tau, and α -synuclein, here we highlight Lys-binding inhibitors of abnormal protein self-assembly leading to preclinical therapeutic applications for the central nervous system.

15 July 2026 in Nature Communications
Verified
Journal Article
Open access
Kazuma MurakamiKazuma Murakami
Kazuma Murakami
Thi Hong Van NGUYENThi Hong Van NGUYEN
Thi Hong Van NGUYEN
LTLeo Tsuda
Leo Tsuda
ECEsha Chawla
Esha Chawla
YWYangxia Wang
Yangxia Wang
Gal BitanGal Bitan
Gal Bitan
The aggregation of α-synuclein (αSyn), a 140-mer protein, has been implicated in the pathogenesis of Parkinson's disease, multiple system atrophy, and dementia with Lewy bodies. KTKEGV pseudo-repeats (KRs) in the sequence of αSyn are key mediators of its prion-like propagation and neurodegeneration. Despite the availability of symptomatic treatments, no current therapy effectively delays disease progression. Here we report a 77-nucleotide RNA aptamer called 1R6, obtained through in vitro selection, that binds with high affinity and selectivity to αSyn1-95. 1R6 significantly inhibits αSyn oligomerization and β-sheet-rich fibril assembly and promotes disaggregation of preformed fibrils. Additionally, 1R6 suppresses αSyn seeding, as determined by a FRET-based biosensor-cell assay. Cellular studies reveal that 1R6 co-transfection completely prevents αSyn-induced cytotoxicity. To assess the protective effects of 1R6 in vivo, we use a Drosophila melanogaster model expressing human αSyn in neurons. Flies fed 1R6 show improved locomotor activity, reduced photoreceptor degeneration, and decreased αSyn levels in the head. Structural characterization using 1H-15N heteronuclear multiple quantum correlation nuclear magnetic resonance experiments demonstrates that 1R6 targets KR motifs, a finding further supported by in silico simulations. Our findings support further development of RNA aptamers, such as 1R6, including evaluation of efficacy, stability, delivery, and immune responses in mammalian systems, highlighting their potential as therapeutic candidates for synucleinopathies.